Advanced Pharmaceutical Bulletin
Tabriz University of Medical Sciences
Journal websitePeer review: Other
Evaluation status available after sign-in
About the journal
Advanced Pharmaceutical Bulletin is an open-access journal published by Tabriz University of Medical Sciences in Iran, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Tabriz University of Medical Sciences
- ISSN
- 2228-5881 · 2251-7308
- Country
- Iran
- Languages
- english
- Access
- Open access
- Articles in DOAJ
- 1169
- Declared review time
- 12 weeks
- Declared peer-review model
- other
- Official website
- https://apb.tbzmed.ac.ir/
Index listings
- DOAJ · 2011-12-30
- Indexing
- DOAJ
- APC
- —
- Declared review time (DOAJ)
- 12 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1169
Most recent article
3 months ago
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
979
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
65
i10-index
497
From OpenAlex open data (CC0).
Editorial & policy10
- Last DOAJ review date
- 2025-05-04
- Added to DOAJ
- 2011-12-30
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 17%
- ORCID iDs in current deposits
- 99%
- Enrolled in Crossref Similarity Check
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101578021
Classification2
Subjects (DOAJ)
Medicine: Therapeutics. Pharmacology
LCC codes
RM1-950
Subject areas
- Advanced Drug Delivery Systems
- Advanced Drug Delivery Systems
- Advanced Drug Delivery Systems
- Nanoparticle-Based Drug Delivery
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Advancements in Transdermal Drug Delivery
- Advancements in Transdermal Drug Delivery
Show all subjects (75)
- Nanoparticle-Based Drug Delivery
- Drug Solubulity and Delivery Systems
- Drug Solubulity and Delivery Systems
- Nanoparticle-Based Drug Delivery
- Mesenchymal stem cell research
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Mesenchymal stem cell research
- Mesenchymal stem cell research
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Medicinal Plant Research
- RNA Interference and Gene Delivery
- MicroRNA in disease regulation
- Electrospun Nanofibers in Biomedical Applications
- Electrospun Nanofibers in Biomedical Applications
- Analytical Methods in Pharmaceuticals
- Monoclonal and Polyclonal Antibodies Research
- Nanoplatforms for cancer theranostics
- Extracellular vesicles in disease
- Immunotherapy and Immune Responses
- Monoclonal and Polyclonal Antibodies Research
- Curcumin's Biomedical Applications
- Hydrogels: synthesis, properties, applications
- Protein purification and stability
- Essential Oils and Antimicrobial Activity
- Curcumin's Biomedical Applications
- Essential Oils and Antimicrobial Activity
- Nanoparticles: synthesis and applications
- Crystallization and Solubility Studies
- Nanoplatforms for cancer theranostics
- Nanoplatforms for cancer theranostics
- Lipid Membrane Structure and Behavior
- Lipid Membrane Structure and Behavior
- Electrospun Nanofibers in Biomedical Applications
- Extracellular vesicles in disease
- Angiogenesis and VEGF in Cancer
- Bee Products Chemical Analysis
- Inhalation and Respiratory Drug Delivery
- Bee Products Chemical Analysis
- Cancer-related molecular mechanisms research
- Hematopoietic Stem Cell Transplantation
- Circular RNAs in diseases
- Extracellular vesicles in disease
- Circular RNAs in diseases
- SARS-CoV-2 and COVID-19 Research
- Monoclonal and Polyclonal Antibodies Research
- Nanoparticles: synthesis and applications
- Analytical Methods in Pharmaceuticals
- Computational Drug Discovery Methods
- Analytical Methods in Pharmaceuticals
- Nanoparticles: synthesis and applications
- Cell death mechanisms and regulation
- Immunotherapy and Immune Responses
- Computational Drug Discovery Methods
- Cancer, Hypoxia, and Metabolism
- Computational Drug Discovery Methods
- Cancer, Hypoxia, and Metabolism
- Crystallization and Solubility Studies
- Crystallization and Solubility Studies
- Cancer-related molecular mechanisms research
- Virus-based gene therapy research
- Virus-based gene therapy research
- Graphene and Nanomaterials Applications
- Graphene and Nanomaterials Applications
- Immunotherapy and Immune Responses
- Cancer-related molecular mechanisms research
Keywords (DOAJ)
- pharmaceutical sciences
- pharmacokinetics
- biopharmaceutics
- pharmacodynamics
- pro-drug developments
- dosage form design
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ